Lack of BRAF V600E Mutation in Human Myeloma Cell Lines Established From Myeloma Patients With Extramedullary Disease

Blood Cancer Journal - United States
doi 10.1038/bcj.2013.60
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A High-Risk Signature for Patients With Multiple Myeloma Established From the Molecular Classification of Human Myeloma Cell Lines

Haematologica
Hematology
2010English

Human Myeloma Cell Line (KHM-4) Established From a Patient With Multiple Myeloma Associated With Hyperammonemia.

Internal Medicine
Internal MedicineMedicine
1992English

An Imaging Review of Extramedullary Myeloma

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2015English

Successful Treatment of Extramedullary Tumors With Low-Dose Thalidomide in Patients With Multiple Myeloma

Internal Medicine
Internal MedicineMedicine
2010English

Incidence and Clinical Features of Extramedullary Multiple Myeloma in Patients Who Underwent Stem Cell Transplantation

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Incidence and Clinical Features of Extramedullary Multiple Myeloma in Patients Who Underwent Stem Cell Transplantation

British Journal of Haematology
Hematology
2015English

A Rare Case of Multiple Myeloma With Intracranial Extramedullary Relapse: One or More Myeloma Clones?

Clinical Case Reports
Medicine
2019English

Chromothripsis 18 in Multiple Myeloma Patient With Rapid Extramedullary Relapse

Molecular Cytogenetics
BiochemistryMolecular MedicineGeneticsMolecular Biology
2018English

Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma With Extramedullary Disease

Cancers
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy